Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction

E-ISSN： 1873-4286|19|18|3190-3200

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.18, 2013-06, pp. : 3190-3200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Status and future direction of male contraceptive development

By Lyttle C.R. Kopf G.S.

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 667-671

Elsevier

Access to resources Recommend Favorite

Assessing Psychiatric Adverse Effects during Clinical Drug Development

By Rudorfer Matthew V.

Pharmaceutical Medicine, Vol. 26, Iss. 6, 2012-12 ,pp. : 363-394

Adis International

Access to resources Recommend Favorite

Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective

By Tang Wei Lu Anthony Y.H.

Drug Metabolism Reviews, Vol. 42, Iss. 2, 2010-05 ,pp. : 225-249

Informa Healthcare

Access to resources Recommend Favorite

Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

Current Cancer Drug Targets, Vol. 11, Iss. 3, 2011-03 ,pp. : 239-253

Bentham Science Publishers

Access to resources Recommend Favorite

Minimising the Adverse Effects of Ketorolac

By Reinhart D.J.

Drug Safety, Vol. 22, Iss. 6, 2000-06 ,pp. : 487-497

Adis International

Access to resources Recommend Favorite